Pharyngeal Chlamydia Guide for Men: Symptoms, Testing, Treatment

Pharyngeal chlamydia is the infection of the throat mucosa (pharynx, tonsils, base of tongue) by Chlamydia trachomatis. C. trachomatis primarily targets columnar/transitional epithelium and traditionally caused urethritis and cervicitis, but oral sex has dramatically expanded throat infection cases worldwide. Japanese national surveillance reports approximately 30,000 chlamydia cases annually, with an estimated 5-15% being pharyngeal infections in men.

The hallmark of pharyngeal chlamydia is silent long-term carriage with intermittent transmission to sexual partners. Unlike urethral chlamydia which often resolves with antibiotics quickly, pharyngeal infection is harder to clear due to lower antibiotic penetration into throat tissue, requiring proper dose and duration of therapy.

The most defining feature of pharyngeal chlamydia is asymptomatic infection in 50-80% of men. Symptomatic patients experience mild throat discomfort, slight pain on swallowing, post-nasal drip, or low-grade fever – symptoms easily attributed to common cold or seasonal allergies.

• Mild throat discomfort and irritation (most common)
• Light sore throat that doesnt impair eating
• Post-nasal drip with yellowish phlegm
• Tonsillar redness and slight swelling
• Mild cervical lymphadenopathy
• Low-grade fever (37 degree range, occasionally 38)

These symptoms are clinically indistinguishable from viral or streptococcal pharyngitis without specific PCR testing for C. trachomatis. Sexual contact history (especially oral sex) should always prompt suspicion.

Pharyngeal chlamydia is primarily transmitted via oral sex (fellatio, cunnilingus) and deep kissing. The bacteria travel from infected genital or oral mucosa to the throat through direct mucosal contact. The popular belief that “oral sex is safe sex” is incorrect – chlamydia, gonorrhea, syphilis, HPV, and herpes can all transmit via oral routes.

• Fellatio (penis to throat): Highest risk if partner has urethral chlamydia
• Cunnilingus (vagina to throat): Risk if partner has cervical chlamydia
• Deep kissing (throat to throat): Moderate risk if both carriers
• Casual kissing: Very low risk
• Shared utensils/towels: Negligible (chlamydia dies quickly outside body)

Many infected partners are unaware they are carriers. New partner screening before unprotected sexual activity is the most rational preventive approach.

The incubation period for pharyngeal chlamydia is 1-3 weeks, longer than gonorrhea (2-7 days). PCR testing reaches optimal sensitivity 1-2 weeks post-exposure. Many cases remain asymptomatic indefinitely until detected by routine STI screening or partner notification.

The current gold standard for pharyngeal chlamydia diagnosis is nucleic acid amplification testing (NAAT/PCR) with sensitivity over 95% and specificity over 99%. Sample collection uses gargle solution (patient self-collected, painless) or pharyngeal swab. Combined chlamydia/gonorrhea PCR panels are now standard and provide results within 1-3 days.

• Gargle PCR: Self-collected, painless, sensitivity 95%+
• Pharyngeal swab PCR: Equivalent sensitivity, mild gag reflex
• Bacterial culture: Less sensitive (50-70%), historic method
• Antibody testing: Limited utility for current infection

Window period: PCR positive from 7-14 days post-exposure. Test of cure: 4 weeks post-treatment to confirm eradication.

Pharyngeal chlamydia is treated with oral antibiotics:

• Azithromycin 1g single dose orally – simplest, high compliance
• Doxycycline 100mg twice daily for 7 days – higher cure rate for pharyngeal infection
• Levofloxacin 500mg daily for 7 days – alternative

Cure rates: 90-95% with proper completion. Pharyngeal chlamydia has lower cure rates than urogenital, so test of cure at 4 weeks post-treatment is recommended. Concurrent gonorrhea testing/treatment is standard given 20-40% co-infection.

Untreated pharyngeal chlamydia leads to: continuous partner transmission, reactive arthritis, increased HIV acquisition risk (2-3x), female partner pelvic inflammatory disease/infertility, and recurrent infection (no protective immunity).

Prevention combines condom use during oral sex, screening before new partners, and prompt partner testing/treatment when diagnosed. Regular screening every 3-6 months for sexually active men is recommended.

Mens Care Clinic provides same-day pharyngeal chlamydia PCR testing and prompt antibiotic prescription. Concurrent gonorrhea testing and full STI panel screening (HIV, syphilis) available. Private rooms, male-staff-led environment, no contact with other patients. Three locations: Shimbashi, Akihabara, Omotesando.

Common questions answered by Mens Care Clinic physicians.